Longitudinal biomarker analysis and outcomes for patients (pts) treated with neoadjuvant nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma Meeting Abstract
| Authors: | Burton, E.; Wani, K.; Milton, D.; Lazcano, R.; Tetzlaff, M.; Ross, M. I.; Postow, M. A.; Glitza, I. C.; Wong, M. K. K.; Patel, S.; Davies, M.; Gershenwald, J. E.; Mcquade, J.; Prieto, V.; Ariyan, C. E.; Wargo, J.; Tawbi, H. A.; Amaria, R. N. |
| Abstract Title: | Longitudinal biomarker analysis and outcomes for patients (pts) treated with neoadjuvant nivolumab (nivo) and relatlimab (rela) in surgically resectable melanoma |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S720 |
| End Page: | S721 |
| Language: | English |
| ACCESSION: | WOS:001326612901392 |
| DOI: | 10.1016/j.annonc.2024.08.1157 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1089P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
